CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma

OBJECTIVE: Our previous study suggested cyclin-dependent kinase-like 3 (CDKL3) acts as a new oncogene in esophageal squamous cell carcinoma (ESCC) cell line TE-1. However, the molecular mechanisms and biological effects of CDKL3 in ESCC remain unknown. In the present study, we aimed to explore the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Suna, Zhang, Mingxin, Zhou, Chao, Wang, Wei, Yang, Haihua, Ye, Wenguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473399/
https://www.ncbi.nlm.nih.gov/pubmed/32974198
http://dx.doi.org/10.3389/fonc.2020.01602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473399/
https://www.ncbi.nlm.nih.gov/pubmed/32974198
http://dx.doi.org/10.3389/fonc.2020.01602

Ejemplares similares